-+ 0.00%
-+ 0.00%
-+ 0.00%

AIM ImmunoTech FY 2024 GAAP EPS $(0.31) Beats $(0.34) Estimate, Sales $170.000K Beat $145.000K Estimate

Benzinga·03/27/2025 12:15:08
Listen to the news
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.34) by 8.82 percent. This is a 48.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $170.000 thousand which beat the analyst consensus estimate of $145.000 thousand by 17.24 percent. This is a 15.84 percent decrease over sales of $202.000 thousand the same period last year.